EDTUTC-4 New YorkLog in Sign up

LKFT
Lakefront Biotherapeutics
stockNASDAQADR

At CloseOct 2, 2026 3:59:55 PM EDT

29.40USD+1.871%(+0.54)270,231

Loading…

Loading…

1.92B

Previous Close

$28.86

Beta

0.30

52-Week High

$32.41 2026-09-23

52-Week Low

$25.68 2026-08-06

SMA 50

$28.31

SMA 200

$28.48

Avg. Vol 10D

318,856

Avg. Vol 30D

288,992

Avg. Vol 90D

233,648

Relative Vol

0.94

65.48M

49.19M

75.12%

3,413,512

Short Interest %

6.94%

12.35

On/Off Exchange

59%/41%

58.95%

Short Vol % (off-exch)

46.28%

0.7700%

650,000

582

1,143

2,550

Sep 23, 2026

04:44 AM EDTRBC upgrades Lakefront Biotherapeutics stock rating on autoimmune drug potential ·

Investing.com

Sep 21, 2026

05:02 AM EDTLakefront Biotherapeutics Targets 2027 Registrational Trials for Gamgertamig ·

MarketBeat

Sep 16, 2026

02:01 AM EDTLakefront Biotherapeutics NV (LKFT) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript ·

Seeking Alpha

Aug 24, 2026

04:01 PM EDTLakefront Receives Transparency Notification from Bank of America ·

GlobeNewswire Inc.

04:01 PM EDTU.S. FDA Grants Orphan Drug Designation to Gamgertamig for the Treatment of Pemphigus ·

GlobeNewswire Inc.

LKFT Performance

Period	Price	Date	Change	Beta
1W	29.84	2026-09-28	-1.51%	1.950
1M	28.49	2026-09-04	+3.16%	1.305
3M	30.35	2026-07-06	-3.16%	0.532
6M	28.59	2026-05-08	+2.80%	0.298

LKFT Stock Summary

Lakefront Biotherapeutics (NASDAQ:LKFT) stock price today is $29.39, and today's volume is 270,234. LKFT is up 1.836% today. The 30 day average volume is 288,992. LKFT market cap is $1.92B with 65.48M shares outstanding.